https://orcid.org/0000-0002-1212-9587
References
- Bresler SC, Padwa BL, Granter SR. Nevoid basal cell carcinoma syndrome (gorlin syndrome). Head Neck Pathol. 2016;10(2):119–124. doi:10.1007/s12105-016-0706-926971503
- Petrova R, Joyner AL. Roles for Hedgehog signaling in adult organ homeostasis and repair. Development. 2014;141(18):3445–3457. doi:10.1242/dev.08369125183867
- Kiwilsza M, Sporniak-Tutak K. Gorlin-Goltz syndrome–a medical condition requiring a multidisciplinary approach. Med Sci Monit. 2012;18(9):Ra145–153. doi:10.12659/MSM.88334122936202
- Odomzo (sonidegib capsules). Full Prescribing Information. Cranbury, NJ, USA: Sun Pharmaceutical Industries, Inc; 2017.
- Migden MR, Guminski A, Gutzmer R, et al. Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial. Lancet Oncol. 2015;16(6):716–728. doi:10.1016/S1470-2045(15)70100-225981810
- Dummer R, Guminksi A, Gutzmer R, et al. Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase 2 randomised, double-blind BOLT study. Br J Dermatol. 2019. doi:10.1111/bjd.18552
- Tang JY, Ally MS, Chanana AM, et al. Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Oncol. 2016;17(12):1720–1731. doi:10.1016/S1470-2045(16)30566-627838224